SESAUA 2020

 "The Contribution of Ascorbic Acid to Urinary Oxalate in Humans". Zachary Burns, Carter Boyd, Nikhi Singh.

"The Contribution of Ascorbic Acid to Urinary Oxalate in a Mouse Model". Zachary Burns, Carter Boyd, Nikhi Singh.

"Opioid Use in Patients with Cystinuria". Nikhi Singh, William Poore, Zachary Burns.

COOKS Conference 2019

View program

CAIRIBU 2019

"The Contribution of Ascorbic Acid to Urinary Oxalate in Humans". Zachary Burns.

WCE 2019

"MP04-18 Association of Obesity with Increased Endogenous Oxalate Synthesis". Zachary Burns, Carter Boyd.

"MP22-04 –Impact of Demographic Factors and Systemic Disease on Urinary Stone Risk Parameters Amongst Stone Former". Zachary Burns, Carter Boyd.

"MP22-07 Screening For Primary Hyperparathyroidism in a Tertiary Stone Clinic: A Useful Endeavor". Carter Boyd.

AUA 2019

"Impact of Demographic Factors and Systemic Disease on Urinary Stone Risk Parameters Amongst Stone Formers". Carter Boyd, Dustin Whitaker.

Poster #11: “Enzymatic Changes in Endogenous Oxalate Pathway in Obese Mouse Model”. Carter Boyd.

Poster #4: “RNA Interference of Hepatic Lactate Dehydrogenase and Liver Metabolomic Effects” Carter Boyd.

SESAUA 2019

"RNA Interference of Hepatic Lactate Dehydrogenase and Liver Metabolomic Effects". Carter Boyd.

"Association of Obesity with Increased Endogenous Oxalate Synthesis". Carter Boyd.

"Enzymatic Changes in Endogenous Oxalate Pathway in Obese Mouse Model". Carter Boyd.

"Impact of Demographic Factors and Systemic Disease on Urinary Stone Risk Parameters Amongst Stone Formers". Carter Boyd.

CAIRIBU 2018

P20: Association of Obesity with Increased Endogenous Oxalate Synthesis". Carter Boyd.

WCE 2018

"MP10-21 Association of Obesity with Increased Endogenous Oxalate Synthesis". Carter Boyd.

"MP2-21 Urinary Oxalate Excretion in Obese Mouse Model". Carter Boyd.

"UP6-40 The Association of Fatty Liver Disease and Urinary Oxalate in Stone Formers". Carter Boyd.

"UP6-57 Screening for Primary Hyperparathyroidism in a Tertiary Stone Clinic: A Useful Endeavor". Carter Boyd.

"MP2-20: RNA Interference of Heaptic Lactate Dehydrogenase Reduces Urinary Oxalate in a Mouse Model of Primary Hyperoxaluria Type 1". Carter Boyd.

SESAUA 2018

"The Association of Fatty Liver Disease and Urinary Oxalate in Stone Formers". Omotola Ashorobi, Carter Boyd.